on Lonza Group AG (isin : CH0013841017)
Lonza CEO to Address Jefferies Global Healthcare Conference
Lonza Group AG has confirmed the participation of CEO Wolfgang Wienand at the Jefferies Global Healthcare Conference in London. The presentation by Wienand is scheduled for 18 November 2026, from 15:30 to 15:55 GMT. A live audio webcast of the session will be available online, with a replay accessible on Lonza's Investor Relations website for 90 days.
The event provides an opportunity to discuss Lonza's strategic direction and insights into the healthcare industry. Lonza operates as a leading contract development and manufacturing organization, collaborating with pharmaceutical and biotech firms worldwide. In the first half of 2026, Lonza achieved sales of CHF 3.4 billion, with a CORE EBITDA of CHF 1.2 billion.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Lonza Group AG news